Eledon Pharmaceuticals (ELDN) EV/EBIT: History & Chart

Eledon Pharmaceuticals, Inc.(ELDN)

Biotechnology · Irvine, CA

$2.46-0.04 (-1.60%)

Delayed quote: Oct 6, 2026, 2:29 PM EDT

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, Eledon Pharmaceuticals, Inc., in January 2021. Its corporate headquarters are located in Irvine, California.

Irvine, CA

33 employees

eledon.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David-Alexandre C. Gros

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Eledon Pharmaceuticals, Inc. (ELDN)	$189.87M	N/A	N/A	N/A	N/A
Zentalis Pharmaceuticals, Inc. (ZNTL)vs ›	$192.20M	N/A	N/A	N/A	N/A
RxSight, Inc. (RXST)vs ›	$192.29M	N/A	N/A	N/A	N/A
AN2 Therapeutics, Inc. (ANTX)vs ›	$183.86M	N/A	N/A	N/A	N/A
Canton Strategic Holdings Inc (CNTN)vs ›	$183.94M	N/A	N/A	N/A	N/A
Oramed Pharmaceuticals Inc. (ORMP)vs ›	$181.47M	N/A	25.06x	25.06x	25.06x
Surrozen, Inc. (SRZN)vs ›	$199.58M	N/A	N/A	N/A	N/A
Compass Therapeutics, Inc. (CMPX)vs ›	$178.59M	N/A	N/A	N/A	N/A
Alector, Inc. (ALEC)vs ›	$200.96M	N/A	19.40x	19.40x	19.40x
Yarrow Bioscience Inc (YARW)vs ›	$177.57M	N/A	0.27x	0.27x	0.27x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Eledon Pharmaceuticals, Inc. (ELDN)

$189.87M

N/A

Zentalis Pharmaceuticals, Inc. (ZNTL)vs ›

$192.20M

N/A

RxSight, Inc. (RXST)vs ›

$192.29M